Antisense oligonucleotide inhibition of papillomavirus

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/37 (2006.01) A61K 48/00 (2006.01) C07H 21/04 (2006.01) C07K 14/025 (2006.01) C12N 15/11 (2006.01) C12Q 1/68 (2006.01) C12Q 1/70 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2070664

Oligonucleotides and oligonucleotide analogs are provided which are capable of antisense interaction with messenger RNA of papillomavirus. Such oligonucleotides or oligonucleotide analogs can be used for diagnostics and therapeutics as well as for research purposes. In accordance with preferred embodiments of this invention, oligonucleotide or oligonucleotide analog is provided which is hybridizable with a messenger RNA from a papillomavirus. The oligonucleotide or oligonucleotide analog is able to inhibit the function of the RNA; and accordingly is useful for therapy for infections by such papillomavirus. In accordance with a preferred embodiment, portions of the papillomavirus are targeted for antisense attack. Thus oligonucleotides are preferably provided which hybridize with the E2; E1, E7, or E6-7 messenger RNAs.

Oligonucléotides et analogues oligonucléotidiques pouvant avoir une action réciproque non codante avec l'ARN messager du virus du papillome. De tels oligonucléotides ou analogues oligonucléotidiques peuvent servir au diagnostic et à la thérapeutique ainsi qu'à des fins de recherche. Selon des modes de réalisation préférés, l'oligonucléotide ou l'analogue oligonucléotidique est hybridable avec un ARN messager provenant d'un virus du papillome, peut inhiber la fonction de l'ARN, et est donc utile à la thérapie des infections provoquées par un tel virus du papillome. Selon un mode de réalisation préféré, on cible des parties du virus du papillome pour une attaque non codante. On peut donc obtenir les oligonucléotides préférables, c'est-à-dire ceux qui s'hybrident avec les ARN messagers E2, E1, E7, ou E6-7.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antisense oligonucleotide inhibition of papillomavirus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotide inhibition of papillomavirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide inhibition of papillomavirus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2058538

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.